Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

GE, Varian to develop pre-clinical 7T MRI system

GE Healthcare and Varian will begin a collaboration to develop a new pre-clinical 7T MRI system.

MRI offers new marker for raised intracranial pressure

MRI measurements of the thickness of the optic nerve sheath are a goodmarker for raised intracranial pressure (ICP), according to researchpublished Thursday in BioMed Central’s open-access journal Critical Care.

Report: Not a lot of progress for EHR adoption

More than three years after President George W. Bush called for all Americans to have EHRs by 2014, a new California HealthCare Foundation report suggests that there has been no measurable increase in health IT adoption.

Report: Not a lot of progress for EHR adoption

More than three years after President George W. Bush called for all Americans to have EHRs by 2014, a new California HealthCare Foundation report suggests that there has been no measurable increase in health IT adoption.

MRI highly sensitive in detecting breast cancer

MR imaging of the breast has high sensitivity and lower specificity forthe detection of breast cancer in patients with breast lesions,according to a study published in the January issue of Radiology.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.